PTGS2 and neoplasm: Since COX-2 expression in pancreatic tumours often is heterogeneous [24,29,30], the actual number of COX-2 positive tumours might be underestimated unless immunohistochemistry is performed on whole slide sections and assessed on multiple different high-power fields within each tumour.